Association between Repeated Unpredictable Chronic Mild Stress (UCMS) Procedures with a High Fat Diet: A Model of Fluoxetine Resistance in Mice
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Major depressive disorder is a debilitating disease. Unfortunately, treatment with antidepressants (ADs) has limited therapeutic efficacy since resistance to AD is common. Research in this field is hampered by the lack of a reliable natural animal model of AD resistance. Depression resistance is related to various factors, including the attendance of cardiovascular risk factors and past depressive episodes. We aimed to design a rodent model of depression resistance to ADs, associating cardiovascular risk factors with repeated unpredicted chronic mild stress (UCMS). Male BALB/c mice were given either a regular (4% fat) or a high fat diet (45% fat) and subjected to two 7-week periods of UCMS separated by 6 weeks. From the second week of each UCMS procedure, vehicle or fluoxetine (10 mg/kg, i.p.) was administrated daily. The effects of the UCMS and fluoxetine in both diet conditions were assessed using physical (coat state and body weight) and behavioural tests (the reward maze test and the splash test). The results demonstrate that during the second procedure, UCMS induced behavioural changes, including coat state degradation, disturbances in self-care behaviour (splash test) and anhedonia (reward maze test) and these were reversed by fluoxetine in the regular diet condition. In contrast, the high-fat diet regimen prevented the AD fluoxetine from abolishing the UCMS-induced changes. In conclusion, by associating UCMS-an already validated animal model of depression-with high-fat diet regimen, we designed a naturalistic animal model of AD resistance related to a sub-nosographic clinical entity of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 2×
“Major depressive disorder is a debilitating disease with a prevalence estimated to be as high as 16.2% according to the National Comorbidity Survey [1].”
MethodInfluentialRush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 4×
“response to desipramine in rats: [25] or bio-markers (mice with a disrupted neurogenesis do not respond to monoaminergic AD: [17,26].”
BackgroundSelf-citationTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“, full resolution of symptoms) occurs in only one third of the patients after treatment with a single drug [2,3].”
BackgroundWillner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993 · cited 1×
“replicates several depression-related behavioural and physiological impairments which are reversed by chronic (but not acute) AD treatment [28,29,30,31].”
BackgroundWillner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 1×
“For studying depressive disorders, the unpredictable chronic mild stress (UCMS) animal model has been shown to be valid, reliable and sensitive [27].”
MethodWillner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · cited 2×
“motivational and apathetic behaviour observed in depression [36].”
BackgroundRush, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1905 · Cited by 870 · cited 1×
“, full resolution of symptoms) occurs in only one third of the patients after treatment with a single drug [2,3].”
BackgroundMRI-defined vascular depression
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.497 · Cited by 770 · cited 1×
“In this subtype of depression, it is suggested that the presence of brain cortical lesion of vascular origin predisposes, precipitates, or perpetuates a depressive state and has a negative impact on treatment outcome [4,5,6].”
BackgroundClinically defined vascular depression
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.562 · Cited by 557 · cited 2×
“Several studies suggest that depressed patients with cerebrovascular lesions show increased resistance to both AD treatment and electroconvulsive therapy [5,6,40,41,42].”
BackgroundSurget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., & Belzung, C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.022 · Cited by 556 · cited 6×
“response to desipramine in rats: [25] or bio-markers (mice with a disrupted neurogenesis do not respond to monoaminergic AD: [17,26].”
BackgroundMethodResultSelf-citationSouery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521 · cited 1×
“Finally, it seems that an increased number of past depressive episodes can also be associated with resistance to AD [14,15].”
BackgroundEffects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice
Mineur, Y. S., Belzung, C., & Crusio, W. E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.029 · Cited by 459 · cited 1×
“However, in order to definitely confirm that we modelled AD resistance induced by vascular risk factors, future studies should use different tests that are not based on food reward such as the resident/ intruder test, the tail suspension test or the forced swim test which have already been used to assess UCMS effects…”
Self-citationPothion, S., Bizot, J.-C., Trovero, F., & Belzung, C. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.008 · Cited by 400 · cited 1×
“Moreover, UCMS-induced grooming perturbation is associated with hedonic reactivity in the sucrose preference test and increased immobility in the force swim test [37,38].”
BackgroundSelf-citationHickie, I., Scott, E., Mitchell, P., Wilhelm, K., Austin, M.-P., & Bennett, B. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00174-2 · Cited by 398 · cited 1×
“Several studies suggest that depressed patients with cerebrovascular lesions show increased resistance to both AD treatment and electroconvulsive therapy [5,6,40,41,42].”
BackgroundUhr, M., Tontsch, A., Namendorf, C., Ripke, S., Lucae, S., Ising, M., Dose, T., Ebinger, M., Rosenhagen, M., Kohli, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.017 · Cited by 382 · cited 1×
“Some are based on the invalidation of genes encoding for proteins involved either in the brain ADs penetration [16] or in the ADs molecular target [17,18,19,20].”
BackgroundAdachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.019 · Cited by 380 · cited 1×
“In some instances, mutant mice only show a blunted response to AD and not a total suppression of the AD effect [21,22,23,24].”
BackgroundAtherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice.
Paigen, B., Ishida, B. Y., Verstuyft, J., Winters, R. B., & Albee, D. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.316 · Cited by 287 · cited 2×
“The BALB/c mice that are the most sensitive to the UCMS procedure need a longer period of high fat diet to react of the cardiovascular effects of this diet [32].”
BackgroundMethodGriebel, G., Stemmelin, J., & Scatton, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.032 · Cited by 253 · cited 1×
“Moreover, UCMS-induced grooming perturbation is associated with hedonic reactivity in the sucrose preference test and increased immobility in the force swim test [37,38].”
BackgroundDucottet, C., Griebel, G., & Belzung, C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00051-4 · Cited by 236 · cited 1×
“replicates several depression-related behavioural and physiological impairments which are reversed by chronic (but not acute) AD treatment [28,29,30,31].”
BackgroundSelf-citationAssociation of low serum total cholesterol with major depression and suicide
Partonen, T., Haukka, J., Virtamo, J., Taylor, P. R., & Lönnqvist, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.3.259 · Cited by 221 · cited 1×
“Although low cholesterol levels have been reported in depressed subjects [10,11], in several studies, hypercholesterolemia, a risk factor for cardiovascular disease, was associated with a poor outcome following AD in major depression [12,13].”
ResultHickie, I., Scott, E., Wilhelm, K., & Brodaty, H. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00363-0 · Cited by 191 · cited 1×
“Several studies suggest that depressed patients with cerebrovascular lesions show increased resistance to both AD treatment and electroconvulsive therapy [5,6,40,41,42].”
BackgroundYalcin, I., Aksu, F., & Belzung, C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.03.029 · Cited by 185 · cited 3×
“The stressors were: altered bedding (change or removal of sawdust, damp sawdust, substitution of sawdust with 21uC water), cage tilting (45u), cage exchange (mice were placed in the empty cage of another male), altered length and time of light/ dark cycle [26,31,33].”
MethodResultSelf-citationMouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey
Yalçın, İ., Belzung, C., & Surget, A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.04.021 · Cited by 183 · cited 3×
“This index has been pharmacologically validated in previous studies using BALB/c mice [26,33,34].”
ResultSelf-citationTreatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Carney, R. M., & Freedland, K. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081239 · Cited by 163 · cited 1×
“Furthermore, treatment-resistant major depression is also frequently described in patients with acute coronary heart disease, and seems to increase risk of mortality after acute coronary syndrome [7].”
BackgroundImpaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice
Steiner, M. A., Wanisch, K., Monory, K., Marsicano, G., Borroni, E., Bächli, H., Holsboer, F., Lutz, B., & Wotjak, C. T. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500466 · Cited by 144 · cited 1×
“In some instances, mutant mice only show a blunted response to AD and not a total suppression of the AD effect [21,22,23,24].”
BackgroundReduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1
Liu, G., Cai, G.-Q., Cai, Y.-Q., Sheng, Z.-J., Jiang, J., Mei, Z., Zhu-gang, W., Guo, L., & Fei, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301281 · Cited by 141
Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal
Ibargüen-Vargas, Y., Surget, A., Touma, C., Palme, R., & Belzung, C. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.010 · Cited by 136
Self-citationKaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135 · cited 1×
“Finally, it seems that an increased number of past depressive episodes can also be associated with resistance to AD [14,15].”
BackgroundCryan, J. F., Dalvi, A., Jin, S., Hirsch, B. R., Lucki, I., & THOMAS, S. A. (2001) · PubMed · Cited by 129
Geriatric depression and vascular diseases: what are the links?
Camus, V., Kraehenbühl, H., Preisig, M., Büla, C., & Waeber, G. (2003) · Journal of Affective Disorders · doi:10.1016/j.jad.2003.08.003 · Cited by 128 · cited 2×
“Several studies suggest that depressed patients with cerebrovascular lesions show increased resistance to both AD treatment and electroconvulsive therapy [5,6,40,41,42].”
BackgroundSelf-citationIbargüen-Vargas, Y., Surget, A., Vourc’h, P., Leman, S., Andres, C. R., Gardier, A. M., & Belzung, C. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.040 · Cited by 122 · cited 2×
“In some instances, mutant mice only show a blunted response to AD and not a total suppression of the AD effect [21,22,23,24].”
BackgroundSelf-citationExecutive Dysfunction, Heart Disease Burden, and Remission of Geriatric Depression
Alexopoulos, G. S., Kiosses, D. N., Murphy, C., & Heo, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300557 · Cited by 117 · cited 2×
“Moreover, cardiovascular risk factors like aging, smoking, hypertension, diabetes, hypercholesterolemia and advanced heart disease predict a poor response to fluoxetine/ citalopram treatment and lack of remission [8,9].”
BackgroundKong, H., Sha, L.-L., Fan, Y., Xiao, M., Ding, J.-H., Wu, J., & Hu, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.185 · Cited by 115
Cerebrovascular Risk Factors and 1-Year Depression Outcome in Older Primary Care Patients
Lyness, J. M., King, D. A., Conwell, Y., Cox, C., & Caine, E. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1499 · Cited by 97 · cited 1×
“Indeed, poor longterm outcomes of depressive symptoms and low rates of remission with selective serotonin reuptake inhibitor (SSRI) treatment are associated with cumulated cardiovascular risk factors and can be predicted by the burden of cardiac disease [8,44].”
BackgroundHigher Prevalence of Depressive Symptoms in Middle-Aged Men With Low Serum Cholesterol Levels
Steegmans, P. H. A., Hoes, A. W., Bak, A. A. A., van der Does, E., & Grobbee, D. E. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200003000-00009 · Cited by 94 · cited 1×
“Although low cholesterol levels have been reported in depressed subjects [10,11], in several studies, hypercholesterolemia, a risk factor for cardiovascular disease, was associated with a poor outcome following AD in major depression [12,13].”
ResultDucottet, C., Aubert, A., & Belzung, C. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.020 · Cited by 80 · cited 3×
“In the regular diet condition, in spite of difference in the time of occurrence, the behavioural alterations induced by UCMS observed in this study replicate the behavioural changes reported in previous studies using the UCMS protocol in mice [26,31,33,34,35].”
BackgroundResultSelf-citationIosifescu, D. V., Clementi-Craven, N., Fraguas, R., Papakostas, G. I., Petersen, T., Alpert, J. E., Nierenberg, A. A., & Fava, M. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000170338.75346.d0 · Cited by 72 · cited 2×
“Moreover, cardiovascular risk factors like aging, smoking, hypertension, diabetes, hypercholesterolemia and advanced heart disease predict a poor response to fluoxetine/ citalopram treatment and lack of remission [8,9].”
BackgroundMast, B. T., Neufeld, S. W., MacNeill, S. E., & Lichtenberg, P. A. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200401000-00012 · Cited by 71 · cited 1×
“A high incidence of depression has been reported when associated with the total burden of vascular risk factors [43] and this so-called cardiovascular risk score (sum of vascular risk factors including aging, smoking cigarette, history family of premature vascular disease, hypertension, diabetes and hypercholesterolem…”
BackgroundYalcin, I., Aksu, F., Bodard, S., Chalon, S., & Belzung, C. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282eff109 · Cited by 68 · cited 1×
“replicates several depression-related behavioural and physiological impairments which are reversed by chronic (but not acute) AD treatment [28,29,30,31].”
BackgroundSelf-citationJama, A., Cecchi, M., Calvo, N., Watson, S. J., & Akil, H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1126-7 · Cited by 62 · cited 1×
“response to desipramine in rats: [25] or bio-markers (mice with a disrupted neurogenesis do not respond to monoaminergic AD: [17,26].”
BackgroundSonawalla, S. B., Papakostas, G. I., Petersen, T. J., Yeung, A. S., Smith, M. M., Sickinger, A. H., Gordon, J., Israel, J. A., Tedlow, J. R., Lamon-Fava, S., et al. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.4.310 · Cited by 62 · cited 1×
“Although low cholesterol levels have been reported in depressed subjects [10,11], in several studies, hypercholesterolemia, a risk factor for cardiovascular disease, was associated with a poor outcome following AD in major depression [12,13].”
ResultInfluentialSerum Cholesterol in Treatment-Resistant Depression
Papakostas, G. I., Petersen, T., Sonawalla, S. B., Merens, W., Iosifescu, D. V., Alpert, J. E., Fava, M., & Nierenberg, A. A. (2003) · Neuropsychobiology · doi:10.1159/000070584 · Cited by 53 · cited 1×
“Although low cholesterol levels have been reported in depressed subjects [10,11], in several studies, hypercholesterolemia, a risk factor for cardiovascular disease, was associated with a poor outcome following AD in major depression [12,13].”
ResultInfluentialStewart, L. Q., Roper, J. A., Young, W. S., O’Carroll, A., & Lolait, S. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.009 · Cited by 44 · cited 1×
“In some instances, mutant mice only show a blunted response to AD and not a total suppression of the AD effect [21,22,23,24].”
BackgroundUnpredictable chronic mild stress in mice
Surget, A., & Belzung, C. (2008) · Enlighten: Publications (University of Glasgow) · Cited by 40
Self-citationBallenger, J. C. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79088-1 · Cited by 27
Mast, B. T. (2004) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.12.1.93 · Cited by 22
Buckley, P. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79186-2 · Cited by 7
Jans, Bouckaert, F., Wils, V., & Peuskens, J. (2006) · PubMed · Cited by 2
Cited by
Sex-specific transcriptional signatures in human depression
Labonté, B., Engmann, O., Purushothaman, I., Menard, C., Wang, J., Tan, C., Scarpa, J. R., Moy, G., Loh, Y.-H. E., Cahill, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4386 · Cited by 748
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Self-citationAnimal models of major depression: drawbacks and challenges
Planchez, B., Surget, A., & Belzung, C. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02084-y · Cited by 480
Self-citationModeling anxiety using adult zebrafish: A conceptual review
Stewart, A., Gaikwad, S., Kyzar, E., Green, J., Roth, A., & Kalueff, A. V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.037 · Cited by 405
“…energy and/or decreased novelty seeking associated with an extended stress period (Piato et al., 2011) e a phenotype resembling rodent chronic unpredictable stress, with anhedonia and reduced self-care behavior and exploration (Isingrini et al., 2010; Pandey et al., 2010; Kazlauckas et al., 2011).”
Hodes, G. E., Pfau, M. L., Purushothaman, I., Ahn, H. F., Golden, S. A., Christoffel, D. J., Magida, J., Brancato, A., Takahashi, A., Flanigan, M. E., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1392-15.2015 · Cited by 395
“Testing was based on a published protocol (Isingrini et al., 2010).”
Method
Metadata
- Authors
- Isingrini, E., Camus, V., Le Guisquet, A.-M., Pingaud, M., Devers, S., & Belzung, C.
- Affiliations
- Université de Tours (FR)
- Corresponding author
- Isingrini, Elsa
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-28
- Volume
- 5
- Issue
- 4
- Pages
- e10404
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2861008
- OpenAlex
- W1999807139
- Semantic Scholar
- 0f4a599df485b0202c2412b4c62b0f2ecc245798
- Cited by
- 277
- References
- 48
- Citations by year
- 2026: 20 · 2025: 31 · 2024: 21 · 2023: 22 · 2022: 28 · 2021: 27 · 2020: 21 · 2019: 19 · 2018: 13 · 2017: 16 · 2016: 13 · 2015: 14 · 2014: 7 · 2013: 5 · 2012: 10
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressant resistance, fluoxetine, chronic unpredictable mild stress, high-fat diet, major depressive disorder, animal models of depression, anhedonia, cardiovascular risk factors, BALB/c mice
- MeSH terms
- Animals, Behavior, Animal, Dietary Fats, Disease Models, Animal, Drug Resistance, Fluoxetine, Male, Mice, Inbred BALB C, Stress, Psychological, Selective Serotonin Reuptake Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.